Groupe Bruxelles Lambert (“GBL”) is an established investment holding company,
with seventy years of stock exchange listing, a net asset value of €14 billion and a market capitalization of €10 billion at the end of December 2025.
GBL is a leading investor in Europe, focused on long-term value creation and relying on a stable and supportive family shareholder base.
Portfolio value €12.8 billion
Sectoral exposure
Listed assets
Direct private assets
Non-core asset class
6.6%
Dividend yield
as of 12/31/2025
€ 14.0 bn
Net asset value
as of 12/31/2025
Financial calendar
2026
7Apr
Publication of the Annual Report 2025
7May
Results as at March 31, 2026
7May
Ordinary General Meeting 2026
30Jul
Half-year results 2026
Press releases
2026
GBL exits its position in Umicore in the context of portfolio simplification, one of the group’s key strategic priorities
GBL invests in Rayner, a leading ophthalmic MedTech specialist, as part of the group’s mid-term strategy execution
Annual & Half-year Reports
2025
Half-yearly report as of June 30, 2025
(interactive version)
2024
